Onconetix (ONCO)

• Market cap: $2.75M
• 1 day: -3.8%
• 5 days: -25.32%
• 1 month: -25.94%
• 3 months: -40.4%
• 6 months: -57.76%
• Year to date: -96.8%
• 1 year: -94.22%
• 5 years: -100%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

Employees: 5